Hideki Kusagaya
Hideki Kusagaya publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.
- World rank
- #2,034,690 of 7,710,434 ranked researchers
- Rank in Japan
- #37,312 of 383,136
- Works
- 36
- Citations
- 784
- Citations per work
- 21.8
What does Hideki Kusagaya research?
Hideki Kusagaya's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2465.4%
- Medicine2465.4%
- Everything else1027.0%
- Life Sciences37.6%
- 1Pulmonary and Respiratory Medicine36% of their works
- 2Oncology15% of their works
- 3Epidemiology8% of their works
- 4Surgery6% of their works
- 5Immunology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Diagnosis and Treatment
- Inflammatory Myopathies and Dermatomyositis
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Nausea and vomiting management
Which keywords describe Hideki Kusagaya's research?
The keywords of their largest research topics: Interstitial Lung Disease, Chemotherapy, Clinical Trials, Targeted Therapy, Fibrosis, Idiopathic Pulmonary Fibrosis, ALK Inhibitors and EGFR Mutations.
- Vomiting Prevention
- Postoperative Nausea
- Genomic Profiles
- Inflammatory Myopathies
- Lung Cancer
- PD-1 and PD-L1
- EGFR Mutations
- Idiopathic Pulmonary Fibrosis
- Targeted Therapy
- Chemotherapy
- Interstitial Lung Disease
- Clinical Trials
- Fibrosis
- ALK Inhibitors
- Immune Checkpoint Blockade
- CT Screening
- Dermatomyositis
- Cetuximab
- KRAS Mutations
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Interstitial Lung Disease142 topics
- Chemotherapy133 topics
- Clinical Trials122 topics
- Targeted Therapy122 topics
- Fibrosis101 topic
- Idiopathic Pulmonary Fibrosis101 topic
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
- Immune Checkpoint Blockade81 topic
- PD-1 and PD-L181 topic
- CT Screening71 topic
- Lung Cancer71 topic
- Dermatomyositis41 topic
- Inflammatory Myopathies41 topic
- Cetuximab31 topic
- Genomic Profiles31 topic
- KRAS Mutations31 topic
- Postoperative Nausea31 topic
- Small-Cell Lung Cancer31 topic
- Vomiting Prevention31 topic
Where does Hideki Kusagaya work?
Hideki Kusagaya's main affiliation in the publication record is Hamamatsu University School of Medicine, Japan.
How many publications and citations does Hideki Kusagaya have?
OpenAlex counts 36 works and 784 citations for Hideki Kusagaya, an h-index of 14, ranking #2,034,690 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hideki Kusagaya. Posts are plain text and can be reported.